Zutron Pharmaceuticals Successfully Launches Advy Actim® PROM and Actim® Partus in Ghana
Accra, Ghana – June 2025
Zutron Pharmaceuticals Limited has successfully launched Advy Actim® PROM and Advy Actim® Partus in Ghana, reinforcing its commitment to advancing maternal healthcare through innovative and high-quality pharmaceutical solutions.
The launch commenced with an in-house product enlightenment and training session for employees of Zutron Pharmaceuticals. This phase was designed to ensure that staff were thoroughly equipped with comprehensive knowledge of the products, enabling effective engagement with healthcare professionals and accurate dissemination of product information.
As part of this initiative, Shaeilandra Kumar a representative of the manufacturer of Advy Actim® PROM and Actim® Partus, visited Ghana to lead an intensive training program. The sessions provided detailed insights into the products’ formulation, clinical applications, benefits, and best practices, strengthening the technical and professional capacity of the Zutron team.
Following the internal launch, Zutron Pharmaceuticals extended the rollout to selected key healthcare facilities across Accra. These engagements were conducted at Korle-Bu Teaching Hospital, The Bank Hospital, the University of Ghana Medical Centre (UGMC), the University of Ghana Hospital, and Ridge Hospital.
During these visits, healthcare professionals were introduced to the products and provided with practical education on their clinical relevance and appropriate use, further supporting informed clinical decision-making.
The successful launch of Advy Actim® PROM and Advy Actim® Partus underscores Zutron Pharmaceuticals’ dedication to continuous professional education, strong partnerships with global manufacturers, and the delivery of reliable healthcare solutions that support improved maternal health outcomes in Ghana.
For more information about Advy Actim® PROM, Advy Actim® Partus, and other products from Zutron Pharmaceuticals Limited, please visit our website or contact our team directly.
